Search for: "People v. Roche"
Results 61 - 80
of 113
Sorted by Relevance
|
Sort by Date
23 Dec 2015, 4:32 am
In particular, in the Stanford v. [read post]
7 Apr 2023, 7:48 am
Roche-Laguna: there is a gray area. [read post]
11 Feb 2015, 12:23 pm
Bayer’s predecessor, Hoffmann-La Roche, filed a US application for FLANAX in February 2004. [read post]
24 Mar 2008, 8:10 am
App. 1997); Roche v. [read post]
18 Jul 2008, 8:34 am
: (Patent Circle), Tanzania to conduct study on impact of counterfeit medicines: (Afro-IP), US: New rules on generic biological medicines under US Congressional debate: (Intellectual Property Watch), Pharma & Biotech - Products Acular (Ketorolac) – US: CAFC rules against Apotex reverse doctrine of equivalents: Roche Palo Alto & Allergan, Inc v Apotex: (Patent Circle), Carbatrol (Carbamazapine) – US: Federal judge allows Corepharma to seek DJ… [read post]
5 Apr 2013, 1:01 pm
She unfolded the insert and noticed the word “Lariam,” as well as the hexagon logo for Roche. [read post]
3 Mar 2012, 6:48 am
Kendall v. [read post]
20 Jun 2012, 6:43 am
Related posts: Mayo v. [read post]
2 Jun 2011, 12:46 pm
Nail v. [read post]
10 Jun 2009, 10:00 pm
See Mauldin v. [read post]
13 Jun 2011, 12:25 am
MGN LIMITED v. [read post]
15 Jul 2009, 5:15 am
IPAB rejects Novartis’ patent application for Glivec (Intellectual Property Watch) Lescol (Fluvastatin) – Netherlands: No interim relief pending appeal against invalidity, rules District Court of The Hague: Novartis v Mylan and Actavis (PatLit) Levaquin (Levoflaxacin) – Canada: FCA holds generics raising allegations similar to those of previous generics allowed their day in court: Apotex v Janssen-Ortho (Global IP Watch) Lexapro (Escitalopram)… [read post]
15 Oct 2010, 5:29 am
Many big cases are trailing badly; some landmarks have not got a single vote (classics such as Hoffmann-La Roche v Centrafarm and Bristol-Meyers Squibb are devoid of supporters, it seems). [read post]
22 Feb 2008, 6:00 pm
Signature Financial Group, Inc., and AT&T Corp. v. [read post]
18 Oct 2010, 2:01 pm
In Bright v. [read post]
23 Nov 2007, 9:00 am
Astra's Data Exclusivity prevents a European generic launch, until at least 2010.: (Generic Pharmaceuticals & IP), Iressa (gefitinib) - Astrazeneca's Indian patent application rejected: (Generic Pharmaceuticals & IP), Ziagen (Abacavir Hemisulfate Salt) -GSK's application [872/CAL/98; corresponding to Orange Book listed US6294540] opposed by Indian Network for People living with HIV/ AIDS and then withdrawn by GSK: (Generic Pharmaceuticals & IP), Thai… [read post]
12 Mar 2012, 1:47 pm
The ‘Junk’ decision in 2005 (C-188/03, Junk v Kuhnel) has meant, that worker consultations need now take place before any final decision on job losses is taken. [read post]
9 May 2008, 10:30 pm
: (Spicy IP), India: Merck vs Roche: towards differential pricing: (Spicy IP), India/Philippines: Access to drugs: The India/Philippines solution? [read post]
12 Jun 2013, 4:30 am
Roche Laboratories, Inc., 2013 U.S. [read post]
13 Jul 2021, 5:05 am
The Court confronted this directly in Hill v. [read post]
